Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05657990 · ClinicalTrials.gov registry record · Early Phase 1
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
A Early Phase 1 study of Urinary Retention, sponsored by Hackensack Meridian Health.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 46
- Enrollment target
- 4
- Study locations
NCT05657990: Recruiting Early Phase 1 study of Urinary Retention, sponsored by Hackensack Meridian Health.
NCT05657990 is a Early Phase 1 study of Urinary Retention that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 46 participants, below the 136-participant average among 11 other Urinary Retention trials with a reported enrollment target (66% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05657990, a Early Phase 1 study of Urinary Retention, is actively recruiting participants, sponsored by Hackensack Meridian Health.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 46 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.
Primary Outcome
Self-reported void within 6-8 hours post operative
Conditions Studied
Interventions
- DRUG Tamsulosin
Study Locations (4)
New Jersey
- Ocean University Medical Center - Brick
- South Ocean University Medical Center - Manahawkin
- Jersey Shore University Medical Center - Neptune City
- Riverview Medical Center - Red Bank
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
What NCT05657990 shows while recruiting
NCT05657990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 136-participant average among 11 other Urinary Retention trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Urinary Retention appearing as the primary indexed condition, and to 1 intervention - of which Tamsulosin is the first listed.
NCT05657990 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05657990 about?
NCT05657990 is a clinical study titled "Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery". This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of...
What is the current status of trial NCT05657990?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 46 participants. The study started on 2023-04-03. Estimated completion is 2026-12.
What conditions does trial NCT05657990 study?
This clinical trial studies the following conditions: Urinary Retention.
What interventions are being tested in trial NCT05657990?
The interventions under investigation include: Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT05657990?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05657990 being conducted?
This trial has 4 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05657990's enrollment target sits among peer trials
46 9th of 11 higher than 3 of 11 other Urinary Retention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Retention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders
ACTIVE NOT RECRUITING · Early Phase 1
-
Comparison of Urinary Flow Study
RECRUITING · NA
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI